Literatur
Durheim MT et al. Lancet Respir Med. 2015;3(5):388–96
Song JW et al. Eur Respir J. 2011;37(2):356–63
Brown AW et al. Chest. 2015;147(1):173–179
Noble PW et al. Lancet. 2011;377(9779):1760–9
King TE Jr et al. N Engl J Med. 2014;370(22):2083–92
Originalie
Ley B, Swigris J, Day BM et al. Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2017. doi: 10.1164/rccm.201701-0091OC [Epub ahead of print]
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Markart, P., Günther, A. Weniger Hospitalisierung aus respiratorischen Gründen bei IPF mit Pirfenidon. Pneumo News 9, 18–20 (2017). https://doi.org/10.1007/s15033-017-0723-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15033-017-0723-8